Abstract:Background: Multiple Sclerosis (MS) is an autoimmune neurodegenerative disease affecting approximately 3 million people globally. Despite rigorous research on MS, aspects of its development and progression remain unclear. Understanding molecular mechanisms underlying MS is crucial to providing insights into disease pathways, identifying potential biomarkers for early diagnosis, and revealing novel therapeutic targets for improved patient outcomes. Methods: We utilized publicly available RNA-seq data (GSE138614) from post-mortem white matter tissues of five donors without any neurological disorder and ten MS patient donors. This data was interrogated for differential gene expression, alternative splicing and single nucleotide variants as well as for functional enrichments in the resulting datasets. Results: A comparison of non-MS white matter (WM) to MS samples yielded differentially expressed genes involved in adaptive immune response, cell communication, and developmental processes. Genes with expression changes positively correlated with tissue inflammation were enriched in the immune system and receptor interaction pathways. Negatively correlated genes were enriched in neurogenesis, nervous system development, and metabolic pathways. Alternatively spliced transcripts between WM and MS lesions included genes that play roles in neurogenesis, myelination, and oligodendrocyte differentiation, such as brain enriched myelin associated protein ( BCAS1 ), discs large MAGUK scaffold protein 1 ( DLG1 ), KH domain containing RNA binding ( QKI ), and myelin basic protein ( MBP ). Our approach to comparing normal appearing WM (NAWM) and active lesion (AL) from one donor and NAWM and chronic active (CA) tissues from two donors, showed that different IgH and IgK gene subfamilies were differentially expressed. We also identified pathways involved in white matter injury repair and remyelination in these tissues. Differentially spliced genes between these lesions were involved in axon and dendrite structure stability. We also identified exon skipping events and spontaneous single nucleotide polymorphisms in membrane associated ring-CH-type finger 1 ( MARCHF1 ), UDP glycosyltransferase 8 ( UGT8 ), and other genes important in autoimmunity and neurodegeneration. Conclusion: Overall, we identified unique genes, pathways, and novel splicing events affecting disease progression that can be further investigated as potential novel drug targets for MS treatment.

Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis

Exome-Sequence Analyses of Four Multi-Incident Multiple Sclerosis Families

Uncovering genetic mimics in multiple sclerosis: A single-center clinical exome sequencing study

Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis

Susceptibility Genes for Multiple Sclerosis Identified in a Gene-Based Genome-Wide Association Study

Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

Gene-Based Tests of a Genome-Wide Association Study Dataset Highlight Novel Multiple Sclerosis Risk Genes

Utilising multi-large omics data to elucidate biological mechanisms within multiple sclerosis genetic susceptibly loci

Locus for severity implicates CNS resilience in progression of multiple sclerosis

Examination of the shared genetic architecture between multiple sclerosis and systemic lupus erythematosus facilitates discovery of novel lupus risk loci

Brain proteome‐wide association study linking‐genes in multiple sclerosis pathogenesis

GWAS highlights the neuronal contribution to multiple sclerosis susceptibility

Genome sequence analyses identify novel risk loci for multiple system atrophy

Gene expression and alternative splicing analysis in a large-scale Multiple Sclerosis study

A Putative Vulnerability Locus to Multiple Sclerosis Maps to 5p14–p12 in a Region Syntenic to the Murine Locus Eae2

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Probing the basis of disease heterogeneity in multiple sclerosis using genetically diverse mice

[New gene map for multiple sclerosis]

Neuronal vulnerability and multilineage diversity in multiple sclerosis

Exploring the complexity of systemic sclerosis etiology by trio whole genome sequencing

Multi-omics integration prioritizes potential drug targets for multiple sclerosis